Tag: AT&T
-
Abattis Bioceuticals (ATT.C): A grift building over several years until regulators couldn’t ignore it anymore
Several years ago, when Equity.Guru boss Chris Parry was writing at Stockhouse, he was called out to a new client – a company called Abattis Bioceutical (ATT.C). Abattis execs had just signed a marketing deal with Stockhouse to help tell their story to investors, and were excited for what might follow. As Parry tells it,…
-
![Bridgemark-linked Abattis (ATT.C) is getting booted off the CSE]()
Bridgemark-linked Abattis (ATT.C) is getting booted off the CSE
The Canadian Securities Exchange is not known for rigorous compliance protocols. However, it does have some standards, and cannabis health product company Abattis Bioceuticals (ATT.C) was unable to meet them. “The common shares of Abattis Bioceuticals Corp. will be delisted at the market close August 9, 2019,” stated the CSE. The CSE originally halted Abattis…
